Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

pembrolizumab 438 Carboplatin 321 Nivolumab 293 Cyclophosphamide 285 Specimen Handling 257 Paclitaxel 249 Magnetic Resonance Spectroscopy 249 Cisplatin 248 Radiotherapy 218 Dexamethasone 183 Gemcitabine 177 Biopsy 177 durvalumab 169 atezolizumab 149 Doxorubicin 140 Rituximab 138 Lenalidomide 135 Docetaxel 131 Ipilimumab 130 Bevacizumab 128 Radiation 121 Capecitabine 117 Etoposide 116 Oxaliplatin 114 Fluorouracil 110 Pemetrexed 109 Radiosurgery 108 fludarabine 106 venetoclax 102 Prednisone 97

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Interventional × leronlimab × Clear all

NCT06699836 2026-05-18

CLOVER

CytoDyn, Inc.

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡